Biomedical Contract Research & Drug Discovery
Integrated Tissue Dynamics, also called INTIDYN, was established in 2008 by research scientists from Albany Medical College to translate more than 35 years of experience in complex tissue analysis from the laboratory to the development of effective and safe therapeutics. It is a privately-held research and contract services organization located in Rensselaer, N.Y. and serves many of the pharmaceutical industry’s leading companies.
Intidyn ChemoMorphometric Analysis or ITD-CMA is a proprietary analytic platform that can be used in any complex tissue to determine the effect of treatments, diseases, and toxins on healthy tissue. It was developed into a commercial service to meet increasing demand from pharmaceutical companies for integrated analyses that can identify biomarkers and evaluate potential therapeutic strategies. It is currently used by several leading biotechnology and pharmaceutical companies to identify early-stage indications of side effects and to determine if a treatment is accurately targeting the cause of a disease or symptom.
